ACCESSWIRE
24 Jun 2019, 13:05 GMT+10
LONDON, UK / ACCESSWIRE / June 23, 2019 / Kazia Therapeutics (ASX: KZA) has identified a higher maximum tolerated dose (MTD) from a Phase IIa study of its brain-penetrant phosphoinositide 3-kinase (PI3K) inhibitor GDC-0084 in glioblastoma (GBM), which may lead to improved efficacy in the ongoing expansion cohort and planned Phase IIb study. A new collaboration with the Alliance for Clinical Trials in Oncology (Alliance) means Kazia will soon have four clinical trials of GDC-0084 underway in primary or secondary brain cancers. It also expects further preliminary efficacy data from its Cantrixil Phase I study in ovarian cancer in H219. We adjust our valuation to between $64m and $103m.
We adjust our indicative valuation range to $64-103m or $10.27-16.50/ADR (vs $64-111m, $10.31-17.82/ADR), due to revised timelines for post-Phase III approval or single-pivotal-study approval scenarios for GDC-0084. Kazia had $4.1m cash at 31 December 2018 and will likely need to raise funds in H219. We estimate ~$11-15m will be needed to fully fund the GDC-0084 Phase IIb study.
Click here to view the full report.
Subscribe to Edison's content to receive reports by email.
All reports published by Edison are free-to-access and available on the website.
About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
Edison is authorised and regulated by the Financial Conduct Authority.
Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.
For more information please contact Edison:
Dr Dennis Hulme, +61 (0)2 8249 8345
Dr John Savin MBA, +44 (0)20 3077 5735
healthcare@edisongroup.com
Learn more at www.edisongroup.com and connect with Edison on:
LinkedIn https://www.linkedin.com/company/edison-group-
Twitter www.twitter.com/Edison_Inv_Res
YouTube www.youtube.com/edisonitv
SOURCE: Edison Investment Research Limited
Get a daily dose of San Francisco Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to San Francisco Star.
More InformationWASHINGTON, DC - The U.S. Department of Justice last week joined with the U.S. Department of State and the United ...
Florida [US], Dec 07 (ANI): The suspect in Friday's deadly shooting at a naval air station in Pensacola was a ...
WASHINGTON, DC - U.S. investigators are trying to determine what caused a Saudi air force pilot in the United States ...
TEHRAN (Tasnim) - China Friday said it had taken 'reciprocal' measures against US diplomats in the country, who will have ...
Canada recently voted at the United Nations for the establishment of a Palestinian state. At the same time, Canada reiterated ...
PORTLAND, Oregon - Like many Americans, Aaron Cole and his wife had been able to save up a nest egg ...
DELHI, India - Dozens of people have died in a fire in a large factory in Delhi.Fire engines streamed through ...
WASHINGTON, DC - The U.S. Department of Justice last week joined with the U.S. Department of State and the United ...
I have already written a short critique of the majority ruling, and here I wish to expand some of its ...
WASHINGTON, DC - U.S. investigators are trying to determine what caused a Saudi air force pilot in the United States ...
TEHRAN (Tasnim) - China Friday said it had taken 'reciprocal' measures against US diplomats in the country, who will have ...
HYDERABAD, India - Four men accused of the rape and murder of a 27-year old woman veterinarian in Hyderabad, India ...